TuHURA Biosciences, Inc.

NASDAQ:HURA

Biotechnology

Healthcare
$1.37 +6.37%

+$0.14 today

Market cap
$87.31M
Beta
0.01
P/E (TTM)
-4.6
EPS (TTM)
-$0.52
52W Low $0.41High $3.90

Volume 0.19M

Average 0.85M

HURA Short-term Investments

Marketable securities and deposits the company expects to convert to cash within a year.

TuHURA Biosciences, Inc.NASDAQ: HURA

Short-term Investments · Q1 FY2026 · quarter ended Mar 2026

Short-term investments remains negative

Q1 FY2026 short-term investments was $0, compared with $0 a year earlier.

Context

  • Short-term investments amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Short-term investments increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Short-term Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Short-term Investments history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Short-term Investments vs competitors

How HURA compares with its peers on the latest reported figures

  • HURA's Mar 2026 short-term investments of $0 is the 4th highest of the 9 companies compared; the peer median is $0.
  • Short-term investments amounts to 0.0% of total assets for HURA, versus a peer median of 0.0%.
HURA Competitors Peer median
Short-term Investments for HURA and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SEERSeer, Inc.Mar 2026$119.35M -36.3%-27.8%43.9%
ABOSAcumen Pharmaceuticals, Inc.Mar 2026$76.6M -35.6%+9.8%57.3%
INOInovio Pharmaceuticals, Inc.Mar 2026$11.41M -59.9%-59.0%22.9%
HURATuHURA Biosciences, Inc.Mar 2026$0 ——0.0%
IRDOpus Genetics, Inc.Mar 2026$0 -100.0%—0.0%
AGENAgenus Inc.Mar 2026$0 ——0.0%
CGTXCognition Therapeutics, Inc.Mar 2026$0 ——0.0%
SPROSpero Therapeutics, Inc.Mar 2026$0 ——0.0%
MCRBSeres Therapeutics, Inc.Mar 2026$0 ——0.0%
Peer median (excluding HURA) $0-48.1%-27.8%0.0%

Competitors are the stored peer set for HURA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents5.55M14.25M3.67M12.66M3.62M
Short-term Investments00000
Net Receivables0101.42K334.44K222.7K0
Inventory000214.7K0
Other Current Assets135.13K390.35K159.33K316.35K1M
Total Current Assets5.68M14.74M4.16M19.61M4.62M
Property, Plant & Equipment (Net)617.14K418.55K202.99K322.53K685.17K
Goodwill000010.74M
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets103.9K33.77K033.77K11.31M
Total Non-current Assets721.04K452.32K202.99K356.3K22.73M
Total Assets6.4M15.2M4.36M19.97M27.35M
Account Payables413.79K1.92M1.87M3.15M3.77M
Short-term Debt644.07K000197.35K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities456K675K137K1.16M1.53M
Total Current Liabilities7.15M2.87M3.6M5.33M5.92M
Long-term Debt002.32M0303.63K
Deferred Tax Liabilities0000197.92K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities020.74K2.32M42.7K501.55K
Total Liabilities7.15M2.89M5.92M5.37M6.42M
Common Stock4.53K4.53K6.8K42.32K59.34K
Retained Earnings(49.48M)(59.16M)(88.47M)(111.12M)(141.18M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity(747.82K)12.3M(1.56M)14.59M20.93M
Total Debt644.07K138.22K2.34M202.54K700.02K
Net Debt(4.9M)(14.11M)(1.32M)(12.45M)(2.92M)

TuHURA Biosciences, Inc.

NASDAQ:HURA

Intrinsic Alpha fair value

Locked

Current Price

$1.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.